Healthcare Global Enterprises Q4 Results Live : Healthcare Global Enterprises declared their Q4 results on 29 May, 2024. The topline increased by 11.85% & the profit increased by 153.73% YoY. Compared to the previous quarter, the revenue grew by 5.18% and the profit increased by 272.98%.
The Selling, general & administrative expenses declined by 0.62% q-o-q & increased by 11.6% Y-o-Y. The operating income was up by 44.81% q-o-q & increased by 45.45% Y-o-Y.
The EPS is ₹1.28 for Q4 which increased by 113.32% Y-o-Y. Healthcare Global Enterprises has delivered -0.28% return in the last 1 week, -3.16% return in the last 6 months and -2.05% YTD return.
Currently, Healthcare Global Enterprises has a market cap of ₹4986.57 Cr and 52wk high/low of ₹401 & ₹306 respectively. As of 01 Jun, 2024, out of 6 analysts covering the company, 5 analysts have given Buy rating & 1 analyst has given Strong Buy rating. The consensus recommendation as of 01 Jun, 2024, was to Buy.
Healthcare Global Enterprises Financials
Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 493.25 | 468.95 | +5.18% | 440.98 | +11.85% |
Selling/ General/ Admin Expenses Total | 76.85 | 77.33 | -0.62% | 68.86 | +11.6% |
Depreciation/ Amortization | 45.98 | 44.16 | +4.12% | 42.2 | +8.95% |
Total Operating Expense | 444.68 | 435.41 | +2.13% | 407.59 | +9.1% |
Operating Income | 48.57 | 33.54 | +44.81% | 33.39 | +45.45% |
Net Income Before Taxes | 28.22 | 11.06 | +155.15% | 13.14 | +114.76% |
Net Income | 21.26 | 5.7 | +272.98% | 8.38 | +153.73% |
Diluted Normalized EPS | 1.28 | 0.41 | +212.13% | 0.6 | +113.32% |